Invitae CEO and leadership

Sean is chief executive officer of Invitae, whose mission is to bring genetic information into mainstream medicine. Prior to his CEO position, he served as Invitae’s president and chief operating officer. Sean was a co-founder and CEO of Locus Development, an early stage genetic analysis startup that later merged with Invitae. Prior to co-founding Locus, he served as COO at Navigenics, an early leader in personalized medicine. Previously, he has also served as SVP of Marketing and SVP, Life Science Business at Affymetrix as well as VP, Labeling and Detection Business at Invitrogen. In the past, he has also worked at McKinsey & Co. and Molecular Probes. Dr. George holds a B.S. in Molecular Genetics from UCLA, an M.S. in Molecular Biology from UC Santa Barbara, and a Ph.D. in Molecular Genetics from UC Santa Cruz.

Ken oversees growth and scale across all of Invitae’s operations, with a focus on innovation on behalf of patients and clients. Prior to joining Invitae, Ken served as Vice President at Amazon.com, Inc., a multinational and diversified technology company, leading Amazon's Transportation Services, Global Delivery Services, and Global Fulfillment operations and human resources. Before his time at Amazon, Ken served as General Manager of the Material Handling and Underground business division at Caterpillar Inc. and in various senior executive capacities at General Motors Company, including leadership of global manufacturing engineering, advanced technology development, and operations. Ken holds a B.S. in Electrical Engineering from the Georgia Institute of Technology and a MBA from the Massachusetts Institute of Technology Sloan School of Management.

Tom leads the legal and compliance team at Invitae. Tom has a broad-based legal background in the life science and diagnostic industries, having advised both public and private multinational companies on transactional​​ and corporate matters. Prior to joining Invitae, Tom served as associate general counsel at Bio-Rad Laboratories and associate in Orrick's corporate and technology group. Tom holds a B.A. from Stanford University and a law degree from U.C. Berkeley School of Law.

A physician and clinical geneticist with an intense interest in molecular genetics testing and its role in the provision of medical care and disease prevention. I carried out research for over 35 years in the area of cell biology of phosphoinositides and neurodegenerative disease due to abnormalities in alpha-synuclein.

Sean is chief executive officer of Invitae, whose mission is to bring genetic information into mainstream medicine. Prior to his CEO position, he served as Invitae’s president and chief operating officer. Sean was a co-founder and CEO of Locus Development, an early stage genetic analysis startup that later merged with Invitae. Prior to co-founding Locus, he served as COO at Navigenics, an early leader in personalized medicine. Previously, he has also served as SVP of Marketing and SVP, Life Science Business at Affymetrix as well as VP, Labeling and Detection Business at Invitrogen. In the past, he has also worked at McKinsey & Co. and Molecular Probes. Dr. George holds a B.S. in Molecular Genetics from UCLA, an M.S. in Molecular Biology from UC Santa Barbara, and a Ph.D. in Molecular Genetics from UC Santa Cruz.

Sean is chief executive officer of Invitae, whose mission is to bring genetic information into mainstream medicine. Prior to his CEO position, he served as Invitae’s president and chief operating officer. Sean was a co-founder and CEO of Locus Development, an early stage genetic analysis startup that later merged with Invitae. Prior to co-founding Locus, he served as COO at Navigenics, an early leader in personalized medicine. Previously, he has also served as SVP of Marketing and SVP, Life Science Business at Affymetrix as well as VP, Labeling and Detection Business at Invitrogen. In the past, he has also worked at McKinsey & Co. and Molecular Probes. Dr. George holds a B.S. in Molecular Genetics from UCLA, an M.S. in Molecular Biology from UC Santa Barbara, and a Ph.D. in Molecular Genetics from UC Santa Cruz.

Ken oversees growth and scale across all of Invitae’s operations, with a focus on innovation on behalf of patients and clients. Prior to joining Invitae, Ken served as Vice President at Amazon.com, Inc., a multinational and diversified technology company, leading Amazon's Transportation Services, Global Delivery Services, and Global Fulfillment operations and human resources. Before his time at Amazon, Ken served as General Manager of the Material Handling and Underground business division at Caterpillar Inc. and in various senior executive capacities at General Motors Company, including leadership of global manufacturing engineering, advanced technology development, and operations. Ken holds a B.S. in Electrical Engineering from the Georgia Institute of Technology and a MBA from the Massachusetts Institute of Technology Sloan School of Management.

A physician and clinical geneticist with an intense interest in molecular genetics testing and its role in the provision of medical care and disease prevention. I carried out research for over 35 years in the area of cell biology of phosphoinositides and neurodegenerative disease due to abnormalities in alpha-synuclein.